Literature DB >> 11403893

Estrogen receptor beta expression in human prostate tissue.

D Pasquali1, S Staibano, D Prezioso, R Franco, D Esposito, A Notaro, G De Rosa, A Bellastella, A A Sinisi.   

Abstract

Estrogen receptor subtype beta (ERbeta) is highly expressed in rat prostate epithelium, but its presence in human prostate needs to be confirmed. Here we investigated the expression of ERbeta in five benign (normal and/or hyperplastic) and 10 malignant (Gleasons' score 2-7) prostate tissue specimens using immunohistochemistry. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue sections, using a commercially available ERbeta polyclonal antibody developed against the C-terminal amino acid residue. Nuclear ERbeta expression was found in the nuclei of glandular epithelium of benign prostate tissue specimens; faint nuclear ERbeta positivity was also present in a few stromal cells around normal epithelium. Nuclear ERbeta specific immunostaining was undetectable in all prostate cancer sections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11403893     DOI: 10.1016/s0303-7207(01)00418-x

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  Inhibition of androgen-independent prostate cancer by estrogenic compounds is associated with increased expression of immune-related genes.

Authors:  Ilsa M Coleman; Jeffrey A Kiefer; Lisha G Brown; Tiffany E Pitts; Peter S Nelson; Kristen D Brubaker; Robert L Vessella; Eva Corey
Journal:  Neoplasia       Date:  2006-10       Impact factor: 5.715

2.  Estrogen receptor β induces antiinflammatory and antitumorigenic networks in colon cancer cells.

Authors:  Karin Edvardsson; Anders Ström; Philip Jonsson; Jan-Åke Gustafsson; Cecilia Williams
Journal:  Mol Endocrinol       Date:  2011-04-14

Review 3.  Androgens and estrogens in benign prostatic hyperplasia: past, present and future.

Authors:  Tristan M Nicholson; William A Ricke
Journal:  Differentiation       Date:  2011-05-26       Impact factor: 3.880

Review 4.  Estrogens and prostate cancer: etiology, mediators, prevention, and management.

Authors:  Shuk-Mei Ho; Ming-Tsung Lee; Hung-Ming Lam; Yuet-Kin Leung
Journal:  Endocrinol Metab Clin North Am       Date:  2011-07-07       Impact factor: 4.741

5.  Differential expression of estrogen receptor beta isoforms in prostate cancer through interplay between transcriptional and translational regulation.

Authors:  Ming-Tsung Lee; Bin Ouyang; Shuk-Mei Ho; Yuet-Kin Leung
Journal:  Mol Cell Endocrinol       Date:  2013-06-24       Impact factor: 4.102

Review 6.  Estrogen and androgen signaling in the pathogenesis of BPH.

Authors:  Clement K M Ho; Fouad K Habib
Journal:  Nat Rev Urol       Date:  2011-01       Impact factor: 14.432

7.  Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation.

Authors:  Marcia R Saban; Ngoc-Bich Nguyen; Timothy G Hammond; Ricardo Saban
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

8.  Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men.

Authors:  Jane H Zhou; Kevin B Kim; Jeffrey N Myers; Patricia S Fox; Jing Ning; Roland L Bassett; Hassan Hasanein; Victor G Prieto
Journal:  Am J Dermatopathol       Date:  2014-01       Impact factor: 1.533

Review 9.  Loss of ERbeta expression as a common step in estrogen-dependent tumor progression.

Authors:  A Bardin; N Boulle; G Lazennec; F Vignon; P Pujol
Journal:  Endocr Relat Cancer       Date:  2004-09       Impact factor: 5.678

10.  Unique bisphenol A transcriptome in prostate cancer: novel effects on ERbeta expression that correspond to androgen receptor mutation status.

Authors:  Janet K Hess-Wilson; Siobhan L Webb; Hannah K Daly; Yuet-Kin Leung; Joanne Boldison; Clay E S Comstock; Maureen A Sartor; Shuk-Mei Ho; Karen E Knudsen
Journal:  Environ Health Perspect       Date:  2007-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.